Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma

NCT02825147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Nasal Type Extranodal NK/T-Cell Lymphoma

Interventions

DRUG: Pegaspargase
DRUG: Methotrexate
DRUG: Dexamethasone
DRUG: Etoposide
RADIATION: radiotherapy

Sponsor

Ruijin Hospital